Evidence map›Paper›PMID 29732401›Full record

ArticleScience advances2018

Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria.

Alexandra Sakatos, Gregory H Babunovic, Michael R Chase, Alexander Dills, John Leszyk, Tracy Rosebrock, Bryan Bryson, Sarah M Fortune

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Propionylation of Fis K32 inFuture microbiology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Evaluation of cytokine profiles related toFrontiers in immunology · 2024
    Article
  9. Article
  10. NFrontiers in microbiology · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Antimicrobial resistance and mechanisms of epigenetic regulation.Frontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Review
  17. Types and functions of heterogeneity in mycobacteria.Nature reviews. Microbiology · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexandra SakatosDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Gregory H BabunovicDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Michael R ChaseDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-9789-0542
Alexander DillsDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-8770-7935
John LeszykDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 02129, USA.
Tracy RosebrockDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0001-6339-6661
Bryan BrysonDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Sarah M FortuneDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Harvard University · USUniversity of Massachusetts Chan Medical School · US

Funding

Sequencing CoreU19AI109755 · NIAID · HARVARD MEDICAL SCHOOL · PI CHANDLER, DARRELL P, CULHANE, AEDIN C · 2014 to 2018
$29.1M
The roles of genes critical for growth under defined conditions in vitro or duriU19AI107774 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI CARR, STEVEN A, FORTUNE, SARAH · 2013 to 2017
$13.2M
The Graduate Program in Tropical Infectious Diseases (GPiTID)T32AI049928 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Flaminia Catteruccia, Phyllis J. Kanki · 2001 to 2026
$5.0M
NIAID NIH HHS T32 AI049928NIAID NIH HHS U19 AI107774NIAID NIH HHS U19 AI109755
6 · The paper itself

Abstract

There is increasing evidence that phenotypically drug-resistant bacteria may be important determinants of antibiotic treatment failure. Using high-throughput imaging, we defined distinct subpopulations of mycobacterial cells that exhibit heritable but semi-stable drug resistance. These subpopulations have distinct transcriptional signatures and growth characteristics at both bulk and single-cell levels, which are also heritable and semi-stable. We find that the mycobacterial histone-like protein HupB is required for the formation of these subpopulations. Using proteomic approaches, we further demonstrate that HupB is posttranslationally modified by lysine acetylation and lysine methylation. Mutation of a single posttranslational modification site specifically abolishes the formation of one of the drug-resistant subpopulations of cells, providing the first evidence in prokaryotes that posttranslational modification of a bacterial nucleoid-associated protein may epigenetically regulate cell state.

Indexed as

Drug Resistance, BacterialProtein Processing, Post-TranslationalBacterial ProteinsDNA-Binding ProteinsGene Expression Regulation, BacterialHistonesIsoniazidModels, MolecularMutationMycobacteriumProtein ConformationStructure-Activity RelationshipBacterial ProteinsDNA-Binding ProteinsHistonesHupB protein, Mycobacterium tuberculosisIsoniazid

Identifiers

PMID29732401
PMCPMC5931751
OpenAlexW2802875518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.